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858 | Chem. Sci., 2013, 4, 858–862Proof of principle for a molecular 1 : 2 demultiplexer to
function as an autonomously switching theranostic
device†
Sundus Erbas-Cakmak,a O. Altan Bozdemir,c Yusuf Cakmaka and Engin U. Akkaya*ab
Guided by the digital design concepts, we synthesized a two-module molecular demultiplexer (DEMUX)
where the output is switched between emission at near IR, and cytotoxic singlet oxygen, with light at
625 nm as the input (I), and acid as the control (c). In the neutral form, the compound ﬂuoresces
brightly under excitation at 625 nm, however, acid addition moves the absorption bands of the two
modules in opposite directions, resulting in an eﬀective reversal of excitation energy transfer direction,
with a concomitant upsurge of singlet oxygen generation and decrease in emission intensity.Introduction
Ever since the seminal de Silva article was published in 1993,1
chemical logic gate research is in a process of rapid progress
and evolution. Now closing in on its second decade, chemical
equivalents of many two input logic gates were reported,2 along
with more complex digital systems featuring higher levels of
virtual integration.3 Finding tangible applications for these
molecular constructs with digital capabilities has been in the
forefront of research in recent years.4 Progress in this eld was
essentially based on the premise that for molecular logic gates,
while getting their inspiration from their silicon based coun-
terparts in digital electronics, the limitations and potential
opportunities do not necessarily show a one-to-one correspon-
dence. The oen stated limitation of “input–output heteroge-
neity” can be molded into a distinct advantage, since the
outputs can be molecular in nature which may interact with
other, and more complex molecular and supramolecular
phenomena such as metabolism, thus opening a new path to
information processing therapeutic agents.5 In addition, certain
design exibilities available in molecular logic gates, have no
counterparts in semiconductor based analogues. Functional/
virtual integration of logic gates and possibility of superposed
logic gates are just two examples. These two uniquely molecular
features are exploited in a typical design of molecular multi-
plexers6 (MUX) and demultiplexers7 (DEMUX). In digital signalnotechnology, Bilkent University, Ankara,
.tr; Fax: +90 312-266-4068; Tel: +90 312-
y, Ankara, 06800, Turkey
y, Erzurum, 25240, Turkey
(ESI) available: General information
rbance and excitation spectra, singlet
ic details, NMR and mass spectra of
/c2sc21499gprocessing, a multiplexer is a combinatorial circuit which
selects from a number of inputs and directs it to an output. A
demultiplexer is a complementary device, taking a single input
signal and switching it between multiple output signals. Both
can be considered as controlled switches.8
Previously, we have shown4a that even a simple AND logic
gate within the context of photodynamic therapy can bring in
highly precious surplus value of enhanced selectivity. Photo-
dynamic therapy is a non-invasive methodology of treatment
for various cancers and non-cancerous indications.9 This
methodology is based on the excitation of a particular photo-
sensitizer within the tumor tissue, generating singlet oxygen
and other reactive oxygen species (ROS), and thus, regiospe-
cically destroying the targeted tumor. In recent years,
combined diagnosis and therapy functions received particular
attention, with a new buzz word to accompany this heightened
interest: theranostics. The diagnosis component obviously
includes, but is not limited to imaging of the region of interest.
As for therapeutic methodologies, such multifunctional
delivery agents would be useful for photodynamic therapy as
well.
It occurred to us that a molecular DEMUX device, which can
switch between two outputs such as light and cytotoxic singlet
oxygen can be very useful in a photodynamic theranostics
context. Such a molecular device when directed to the tumor
region, may uoresce brightly in the surrounding healthy
tissue, and inside the tumor, appear dark while generating
singlet oxygen on excitation. The switch can be made by the
acidity diﬀerence between the tumors and the healthy tissue
without any need to change the wavelength of excitation. It is
widely known that most tumors are considerably acidic
compared to neighbouring healthy tissues as a result of the
Warburg eﬀect.10 If the design is made properly, the emission
can be at the red or near IR region of the spectrum making
imaging more valuable.This journal is ª The Royal Society of Chemistry 2013
Fig. 2 Absorbance spectra of equal concentrations (2 mM) of the photosensitizer
(PS, 1) and the ﬂuorophore (FL, 2) modules in the presence (dashed curves) and
absence (solid curves) of added TFA in chloroform.
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View Article OnlineResults and discussion
With these goals in mind, we designed a proof-of-principle
DEMUX, which can operate in organic solvents, incorporating
switchable through space energy transfer coupled to mutually
exclusive generation of red/near IR uorescence emission or
singlet oxygen generation depending on the acidity of the
medium. Here, the light at 625 nm (supplied by a LED array) is
the input (I), and the acid (triuoroacetic acid, TFA) is the
control (or address input). The target molecule is composed of
two distyryl-Bodipy modules clicked together by Huisgen
cycloaddition (Scheme S1†). Our previous experience with dis-
tyryl-Bodipys11 taught us that pyridylethenyl and dimethylami-
nophenylethenyl substituted Bodipys respond by opposite
spectral shis on protonation (blue shi with dimethylamino-
phenyl, and red shi with pyridyl) as a result of diﬀerent
internal charge transfer (ICT) characteristics. When excited at a
xed wavelength, it is reasonable to expect a switch in the
direction of energy transfer (Fig. 1, 2 and S1†). Furthermore, one
of the Bodipy modules (2, FL module) is designed to be uo-
rescent, and especially more so on protonation. The other one
(1, the PSmodule) carries heavy atoms (two iodine atoms at 2,6-
positions) facilitating intersystem crossing to yield a higher rate
of singlet oxygen generation. It is clear that the switch is not
going to be absolute, i.e., both modules will be excited at varying
degrees, nevertheless an inspection of Fig. 2 reveals that at the
optimal wavelength (635 nm), the PS to FL absorptivity ratio
changes from 2 to 0.5, altering the position of preferential
initial excitation.Fig. 1 Modular assembly of the molecular DEMUX device with two diﬀerent
outputs depending on the acidity of the medium.
This journal is ª The Royal Society of Chemistry 2013The operation of the DEMUX can be broken down into
superposed action of two modules clicked together. Compound
3 shows a broad band and it is diﬃcult to assess spectral
changes on the addition of control input TFA (Fig. S1†). But,
when the two components are separately studied as indepen-
dent modules, the operation of compound 3 can be better
understood. When no acid is added, maximum absorbance of
the isolated PS module (1) is at 647 nm and that of the FL
module (2) is at 681 nm, however, when TFA is added, the
absorption peak of 1 shis to 671 nm, whereas that of 2 shis to
647 nm (Table 1 and Fig. 2). An opposite shi is also observed in
emission spectra of modules 1 and 2 (Fig. S1†). While the
diﬀerence seems to be small, adding the auxochromic nature of
the protonation of 2, it should not be surprising to see that the
compound 3 works in accordance with the design expectations.
For compound 3, when there is no added acid (c ¼ 0), on
excitation at 625 nm, an intense emission at 715 nm from the FL
module is observed in accordance with the operation of the
DEMUX device corresponding to input hn625 ¼ 1, c ¼ 0; there-
fore output is switched to output 1, which is hn715. Here, we took
advantage of the faster rate of the excited state energy transfer
process with respect to intersystem crossing12 to quench the
singlet oxygen generation near neutral pH and yield near IR
emission instead (vide infra).Table 1 Photophysical characterization of compounds 1, 2 and 3 in chloroform
Compound
labs
[nm] 3 [M1 cm1]
lF
[nm] fF
a [lexc (nm)] sF
b [ns]
1 647 73 000 665 0.22 1.71
1 + H+ 671 53 000 694 0.06 0.33
2 681 68 000 729 0.16 3.37
2 + H+ 647 76 000 665 0.41 3.62
3 652 121 000 715 0.42 4.05
3 + H+ 650 105 000 700 0.02 0.03
a Quantum yields were calculated using Sulforhodamine 101 (excitation
at 550 nm, in EtOH) as reference. All other compounds were dissolved in
chloroform. b All measurements are taken in CHCl3 using 650 nm (for
compounds 1 and 2) and 667 nm (for compound 3) NanoLEDS.
Chem. Sci., 2013, 4, 858–862 | 859
Fig. 3 Emission spectra of the DEMUX device 3, under neutral (black, solid) and
acidic (red, dashed) conditions excited at 625 nm in chloroform. Fig. 4 Singlet oxygen mediated photobleaching of DPBF (50 mM) in the pres-
ence of 20 nM compound 3 and TFA (20 mL/3 mL) in chloroform.
Fig. 5 Truth table (a), circuit diagram (b) and schematic switching operation (c)
of the 1 : 2 molecular DEMUX logic device.
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View Article OnlineExcitation energy transfer (EET) from the PS to FL in DEMUX
compound 3 is conrmed by the decrease in the singlet oxygen
generation capacity of the PSmodule (ESI, Table S1, Fig. S2 and
S3†), even though it actively generates 1O2 when that module
alone was excited separately, both under acidic and neutral
conditions (ESI, Fig. S2 and S3†). On acid addition, (c ¼ 1) and
excitation at the xed wavelength of 625 nm, simultaneous ICT
shis in PS and FL change the direction of EET and cytotoxic
singlet oxygen is then produced, while the emission of FL is
quenched (Fig. 3). Energy transfer to the PS module in
compound 3 is also conrmed by the decrease in the excited
state lifetime of protonated compound 3 (0.03 ns, c2 ¼ 1.43)
compared to the protonated donor FL module (3.62 ns, c2 ¼
1.21) in CHCl3, indicating a very high energy transfer eﬃciency
(99%).
Three negative and two positive control experiments support
the mutually exclusive character of near IR uorescence emis-
sion and singlet oxygen generation (Table 2). In positive
controls, the singlet oxygen generation activity of 20 nM
compound 1 (PS module, same concentration as the demulti-
plexer 3) was studied, and as expected, found to be high, both in
the presence or absence of triuoroacetic acid (ESI, Fig. S2 and
S3†). This shows that the decrease in the singlet oxygen gener-
ation rate is mostly due to the presence of the uorophore
module as an energy sink. The relative singlet oxygen genera-
tion eﬃciencies were calculated by normalizing the rate of
initial decrease in the DPBF degradation/bleaching (ESI†). InTable 2 Experimental data for the generation of photonic and chemical outputs i
Compound Irradiation (625 nm)
H+
(address input)
3 0 0
3 1 0
3 0 1b
3 1 1b
1 0 0
1 1 0
1 0 1
1 1 1
a Relative singlet oxygen generation was calculated by setting the rate of D
added to 3 mL of each sample. Details of calculations were given in the E
860 | Chem. Sci., 2013, 4, 858–862the case of 1 (PS) alone (positive control-1), the eﬃciency seems
to decrease to 0.56 compared to compound 3 under acidic
conditions.
This is probably due to the larger absorptivity of the
protonated FL unit which leads to excitation of the PS in 3 by
EET. The PS under acidic conditions exhibits a decrease in the
rate of 1O2 generation which is due to the decrease in molar
absorptivity at the wavelength of excitation (625 nm) as a result
of the bathochromic shi on protonation. In addition, by usingn response to the input acted by the address switch
Relative emission
intensity (715 nm) Relative 1O2 generation eﬃciency
a
0 0
1 0.14
0 <0.01
0.21 1.0
— 0
— 1
— <0.01
— 0.56
PBF degradation at input ¼ 1, address ¼ 1 case to be 1. b 20 mL TFA was
SI.†
This journal is ª The Royal Society of Chemistry 2013
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View Article Onlinetwo negative controls, it was shown that there is no degradation
of the trap molecule (diphenylisobenzofuran, DPBF) in the
absence of photosensitizer under neutral and acidic conditions
(ESI, Fig. S2 and S3†). The third negative control was carried out
to determine the extent of singlet oxygen generation of
compound 3 under neutral conditions, i.e., in the absence of
added acid. In this experiment, due to eﬀective reversed EET
from the PS to FL, no singlet oxygen generation is observed as
expected (Table 2 and S2†).
Furthermore, control experiments with trap alone were per-
formed to ensure the reliability of the data. In acidic conditions,
reciprocal shis in the absorbance of the two modules of the
compound 3 lead to a change in the direction of EET. The 2 (FL)
becomes the donor, and excitation energy is transferred to 1
(PS), which becomes activated and generates cytotoxic singlet
oxygen eﬀectively at concentrations as low as 20 nM (Fig. 4 and
5). The response of compound 3 and all other control experi-
ments under neutral and acidic conditions in dark and under
red LED irradiation at 625 nm is shown in Table 2.
The overall working principle of the compound presented
here as a molecular DEMUX device is as follows; in the absence
of acid, there is an intense emission near IR at around 715 nm
(Fig. 3). When the acid is added, the uorescence of the
compound 3 is completely quenched due to EET to the non-
emissive PS module. This decrease in emission is linked to the
eﬃcient generation of singlet oxygen. With the pH-driven
change in the EET direction, the PSmodule becomes active and
generates therapeutic output, singlet oxygen. This action is
dependent on the change in EET direction, thus, with a similar
demultiplexer based on this proof of principle, but with addi-
tional practical considerations in mind (solubility, pKa values of
the acid sensitive groups), sensitization to produce singlet
oxygen would be only in the acidic medium (as found in most
tumors) and the boundaries of the tumor region can be imaged
by the change in uorescence intensity (which would appear as
darker regions, as opposed to red/near IR uorescence from the
surrounding healthy tissues).
The demultiplexer device described in this work acts
reversibly and retains most of its uorescence intensity even
aer 5 cycles of pH oscillations (ESI, Fig. S4†).Conclusions
The importance of multifunctional drugs and delivery systems
is well appreciated, and in this work, we demonstrated that the
two critical functions, i.e., diagnostic and therapeutic actions
can be in principle, implemented using a single molecular
agent. We expect this proof of principle model of a demulti-
plexer to pave the way to multifunctional molecular systems,
which would interactively deliver the therapeutic agent, while
oﬀering diagnostic imaging possibilities. It is obvious that the
water solubility issue has to be addressed, and the molecular
device would be even more valuable if it could be transformed
into another one where the emission in the tumor region is
turned on. Regardless, the idea seems to be perfectly transfer-
able to other designs where the practical issues as mentioned
above could be addressed. The work described here suggestsThis journal is ª The Royal Society of Chemistry 2013that even at a relatively rudimentary stage, information pro-
cessing molecules can produce unprecedented capabilities,
such as autonomous decision making to switch between diag-
nostic and therapeutic modes. And this is made possible by a
unimolecular superposed logic operation with no semi-
conductor counterpart. The future of molecular logic gate
research looks very bright.Acknowledgements
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